Stay updated with breaking news from Nasdaq Afmd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com started coverage on shares of Affimed (NASDAQ:AFMD – Free Report) in a report released on Saturday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Other analysts also recently issued reports about the stock. Truist Financial cut their price objective on shares of Affimed from $8.00 to $6.00 and set a […]
Affimed (NASDAQ:AFMD – Get Free Report) has been given an average rating of “Moderate Buy” by the eight brokerages that are covering the stock, Marketbeat.com reports. One analyst has rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 12-month target price among analysts that have […]
StockNews.com began coverage on shares of Affimed (NASDAQ:AFMD – Free Report) in a research report report published on Monday. The firm issued a sell rating on the biopharmaceutical company’s stock. Several other research firms have also commented on AFMD. HC Wainwright reiterated a buy rating and issued a $5.00 target price on shares of Affimed […]
StockNews.com assumed coverage on shares of Affimed (NASDAQ:AFMD – Free Report) in a report released on Sunday. The firm issued a sell rating on the biopharmaceutical company’s stock. A number of other equities research analysts have also weighed in on AFMD. Berenberg Bank restated a buy rating and set a $6.00 price objective on shares […]
Shares of Affimed (NASDAQ:AFMD – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the eight brokerages that are currently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 12-month price objective among […]